Metronomic Oral Paclitaxel Monotherapy for Advanced HER2-Negative Breast Cancer: A Two-Stage Dose-Finding and Expansion Study
Clinical trial NCT07602907 · RECRUITING
Trial details
- NCT number
- NCT07602907
- Sponsor
- Zhejiang Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-04
- Primary completion
- 2029-08-20
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.